FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bryan T. J. Hennessy

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Tumor Cell Line

Procedures

Physiology

Occupations

Proteomics

Devices

Protein Array Analysis

Co-author Network

Publications

TOP 3
Ana M Gonzalez-Angulo; Kirsten M Timms; Shuying Liu; Huiqin Chen; Jennifer K Litton; Jennifer Potter; Jerry S Lanchbury; Katherine Stemke-Hale; Bryan T. J. Hennessy; Banu K Arun; Gabriel N Hortobagyi; Kim-Anh Do; Gordon B Mills; Funda Meric-Bernstam
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Bryan T. J. Hennessy; Kirsten M Timms; Mark S Carey; Alexander Gutin; Larissa A Meyer; Darl D Flake; Victor Abkevich; Jennifer Potter; Dmitry Pruss; Pat Glenn; Yang Li; Jie Li; Ana M Gonzalez-Angulo; Karen Smith McCune; Maurie Markman; Russell R Broaddus; Jerry S Lanchbury; Karen H Lu; Gordon B Mills
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Gordon B Mills
Future of personalized medicine in oncology: a systems biology approach.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bryan T. J. Hennessy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ana M Gonzalez-Angulo; Kirsten M Timms; Shuying Liu; Huiqin Chen; Jennifer K Litton; Jennifer Potter; Jerry S Lanchbury; Katherine Stemke-Hale; Bryan T. J. Hennessy; Banu K Arun; Gabriel N Hortobagyi; Kim-Anh Do; Gordon B Mills; Funda Meric-Bernstam
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1082-9.
2010: Bryan T. J. Hennessy; Kirsten M Timms; Mark S Carey; Alexander Gutin; Larissa A Meyer; Darl D Flake; Victor Abkevich; Jennifer Potter; Dmitry Pruss; Pat Glenn; Yang Li; Jie Li; Ana M Gonzalez-Angulo; Karen Smith McCune; Maurie Markman; Russell R Broaddus; Jerry S Lanchbury; Karen H Lu; Gordon B Mills
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3570-6.
2010: Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Gordon B Mills
Future of personalized medicine in oncology: a systems biology approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(16):2777-83.
2010: Mark S Carey; Roshan Agarwal; Blake Gilks; Kenneth Swenerton; Steve Kalloger; Jennifer Santos; Zhenlin Ju; Yiling Lu; Fan Zhang; Kevin R Coombes; Dianne Miller; David Huntsman; Gordon B Mills; Bryan T. J. Hennessy
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2852-60.
2010: Eun Sung Park; Rosalia Rabinovsky; Mark Carey; Bryan T. J. Hennessy; Roshan Agarwal; Wenbin Liu; Zhenlin Ju; Wanleng Deng; Yiling Lu; hyun goo woo; Sang-Bae Kim; Jae-Ho Cheong; Levi A Garraway; John N Weinstein; Gordon B Mills; Ju-Seog Lee; Michael A Davies
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.
Molecular cancer therapeutics 2010;9(2):257-67.
2010: Pablo Vivas-Mejia; Juliana Maria Benito; Ariel Fernandez; Hee-Dong Han; Lingegowda Mangala; Cristian Rodriguez-Aguayo; Arturo Chavez-Reyes; Yvonne G Lin; Mark S Carey; Alpa M Nick; Rebecca L Stone; Hye Sun Kim; Francois Claret; William G Bornmann; Bryan T. J. Hennessy; Angela M Sanguino; Zhengong Peng; Anil K Sood; Gabriel Lopez-Berestein
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):184-94.
2009: Isabel Blancas; Francisco J Gómez; Begoñia Bermejo; Bryan T. J. Hennessy; Isabel Chirivella; Ana Magro; Antonio Caballero; Jaime Ferrer; Vicente Valero; Ana Lluch
Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories.
Clinical breast cancer 2009;9(4):231-6.
2009: Bryan T. J. Hennessy; Robert L Coleman; Maurie Markman
Ovarian cancer.
Lancet 2009;374(9698):1371-82.
2009: Krishna M Vasudevan; David A Barbie; Michael A Davies; Rosalia Rabinovsky; Chontelle J McNear; Jessica J Kim; Bryan T. J. Hennessy; Hsiuyi Tseng; Panisa Pochanard; So Young Kim; Ian F Dunn; Anna C Schinzel; Peter Sandy; Sebastian Hoersch; Qing Sheng; Piyush B Gupta; Jesse S Boehm; Jan H Reiling; Serena Silver; Yiling Lu; Katherine Stemke-Hale; Bhaskar Dutta; Corwin Joy; Aysegul A Sahin; Ana Maria Gonzalez-Angulo; Ana Lluch; Lucia E Rameh; Tyler Jacks; David E Root; Eric S Lander; Gordon B Mills; William C Hahn; William R Sellers; Levi A Garraway
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
Cancer cell 2009;16(1):21-32.
2009: Rachelle L Dillon; Richard Marcotte; Bryan T. J. Hennessy; James R Woodgett; Gordon B Mills; William J Muller
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
Cancer research 2009;69(12):5057-64.
2009: Roshan Agarwal; Ana M Gonzalez-Angulo; Simen Myhre; Mark Carey; Ju-Seog Lee; Jens Overgaard; Jan Alsner; Katherine Stemke-Hale; Ana Lluch; Richard M Neve; Wen Lin Kuo; Therese Sorlie; Aysegul Sahin; Vicente Valero; Khandan Keyomarsi; Joe Gray; Anne-Lise Borresen-Dale; Gordon B Mills; Bryan T. J. Hennessy
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3654-62.
2009: Robert C Bast; Bryan T. J. Hennessy; Gordon B Mills
The biology of ovarian cancer: new opportunities for translation.
Nature reviews. Cancer 2009;9(6):415-28.
2009: Matthias Niedermeier; Bryan T. J. Hennessy; Zachary A Knight; Marina Henneberg; Jianhua Hu; Antonina V Kurtova; William G Wierda; Michael J Keating; Kevan M Shokat; Jan A Burger
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
Blood 2009;113(22):5549-57.
2009: Yi Chen; Natalia Guggisberg; Merce Jorda; Ana Gonzalez-Angulo; Bryan T. J. Hennessy; Gordon B Mills; Chen-Keat Tan; Joyce M Slingerland
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3396-405.
2009: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Michael Z Gilcrease; Savitri Krishnamurthy; Ju-Seog Lee; Jane Fridlyand; Aysegul Sahin; Roshan Agarwal; Corwin Joy; Wenbin Liu; David N Stivers; Keith A Baggerly; Mark Carey; Ana Lluch; Carlos Monteagudo; Xiaping He; Victor Weigman; Cheng Fan; Juan Palazzo; Gabriel N Hortobagyi; Laura K Nolden; Nicholas J Wang; Vicente Valero; Joe Gray; Charles M Perou; Gordon B Mills
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
Cancer research 2009;69(10):4116-24.
2009: Todd W Miller; Marianela Pérez-Torres; Archana Narasanna; Marta Guix; Olle Stål; Gizeh Pérez-Tenorio; Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Gordon B Mills; J Phillip Kennedy; Craig W Lindsley; Carlos L Arteaga
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
Cancer research 2009;69(10):4192-201.
2009: Asif Loya; Merih Guray; Bryan T. J. Hennessy; Lavinia P Middleton; Thomas A Buchholz; Vicente Valero; Aysegul A Sahin
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Cancer 2009;115(8):1605-12.
2009: Eun-Kyoung Yim; Guang Peng; Hui Dai; R Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T. J. Hennessy; Rolf J Craven; Shiaw-Yih Lin
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
Cancer cell 2009;15(4):304-14.
2009: Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Shana L Palla; Mark Carey; Roshan Agarwal; Funda Meric-Berstam; Tiffany A Traina; Clifford Hudis; Gabriel N Hortobagyi; William L Gerald; Gordon B Mills; Bryan T. J. Hennessy
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2472-8.
2009: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Mark S Carey; Gordon B Mills
A systems approach to analysis of molecular complexity in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):417-9.
2009: Shaheenah Dawood; Kristine Broglio; Shu-Wan Kau; Marjorie C Green; Sharon H Giordano; Funda Meric-Bernstam; Thomas Buchholz; Constance T Albarracin; Wei Tse Yang; Bryan T. J. Hennessy; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):220-6.
2009: Mandi Murph; Wenbin Liu; Shuangxing Yu; Yiling Lu; Hassan Hall; Bryan T. J. Hennessy; John Lahad; Marci Schaner; Aslaug Helland; Gunnar Kristensen; Anne-Lise Børresen-Dale; Gordon B Mills
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PloS one 2009;4(5):e5583.
2008: Woo-Young Kim; Dong Jo Chang; Bryan T. J. Hennessy; Hae Jin Kang; Jakyung Yoo; Seung-Ho Han; Yoo-Shin Kim; Hyun-Ju Park; Seung-Yong Seo; Seung-Yong Geo; Gordon Mills; Kyu-Won Kim; Waun Ki Hong; Young-Ger Suh; Ho-Young Lee
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
Cancer prevention research (Philadelphia, Pa.) 2008;1(7):577-87.
2008: Katherine Stemke-Hale; Ana Maria Gonzalez-Angulo; Ana Lluch; Richard M Neve; Wen-Lin Kuo; Michael Davies; Mark Carey; Zhi Hu; Yinghui Guan; Aysegul Sahin; W Fraser Symmans; Lajos Pusztai; Laura K Nolden; Hugo Horlings; Katrien Berns; Mien-Chie Hung; Marc J van de Vijver; Vicente Valero; Joe Gray; René Bernards; Gordon B Mills; Bryan T. J. Hennessy
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
Cancer research 2008;68(15):6084-91.
2008: Cornelia Liedtke; Chafika Mazouni; Kenneth R Hess; Fabrice André; Attila Tordai; Jaime A Mejia, M.D.; W Fraser Symmans; Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Marjorie Green; Massimo Cristofanilli; Gabriel N Hortobagyi; Lajos Pusztai
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1275-81.
2008: Romesh Stanislaus; Mark Carey; Helena Deus; Kevin R Coombes; Bryan T. J. Hennessy; Gordon B Mills; Jonas Almeida
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays.
BMC bioinformatics 2008;9():555.
2008: Mandi Murph; Debra L Smith; Bryan T. J. Hennessy; Yiling Lu; Corwin Joy; Kevin R Coombes; Gordon B Mills
Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.
Advances in experimental medicine and biology 2008;622():183-95.
2008: Bryan T. J. Hennessy; Mandi Murph; Meera Nanjundan; Mark Carey; Nelly Auersperg; Jonas Almeida; Kevin R Coombes; Jinsong Liu; Yiling Lu; Joe Gray; Gordon B Mills
Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.
Advances in experimental medicine and biology 2008;617():23-40.
2007: Bryan T. J. Hennessy; Yiling Lu; Enrique Poradosu; Qianghua Yu; Shuangxing Yu; Hassan Hall; Mark S Carey; Murali Ravoori; Ana M Gonzalez-Angulo; Robert Birch; I Craig Henderson; Vikas Kundra; Gordon B Mills
Pharmacodynamic markers of perifosine efficacy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7421-31.
2007: Bryan T. J. Hennessy; Michael Z Gilcrease; Edward Kim; Ana M Gonzalez-Angulo
Breast carcinoma with neuroendocrine differentiation and myocardial metastases.
Clinical breast cancer 2007;7(11):892-4.
2007: Wei Tse Yang; Bryan T. J. Hennessy; Kristine Broglio; Chadwick Mills; Nour Sneige; W Grant Davis; Vicente Valero; Kelly K Hunt; Michael Z Gilcrease
Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
AJR. American journal of roentgenology 2007;189(6):1288-93.
2007: Katrien Berns; Hugo Horlings; Bryan T. J. Hennessy; Mandy Madiredjo; E Marielle Hijmans; Karin Beelen; Sabine C Linn; Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Michael Hauptmann; Roderick L Beijersbergen; Gordon B Mills; Marc J van de Vijver; René Bernards
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
Cancer cell 2007;12(4):395-402.
2007: W Fraser Symmans; Florentia Peintinger; Christos Hatzis; Radhika Rajan; Henry M Kuerer; Vicente Valero; Lina Assad; Anna Poniecka; Bryan T. J. Hennessy; Marjorie Green; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4414-22.
2007: Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Kristine Broglio; Funda Meric-Bernstam; Massimo Cristofanilli; Sharon H Giordano; Thomas Buchholz; Aysegul Sahin; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobágyi
Trends for inflammatory breast cancer: is survival improving?
The oncologist 2007;12(8):904-12.
2007: Isabel Chu; Angel Arnaout; Sophie Loiseau; Jun Sun; Arun Seth; Chris McMahon; Kathy Chun; Bryan T. J. Hennessy; Gordon B Mills; Zafar Nawaz; Joyce M Slingerland
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
The Journal of clinical investigation 2007;117(8):2205-15.
2007: Jianhua Hu; Xuming He; Keith A Baggerly; Kevin R Coombes; Bryan T. J. Hennessy; Gordon B Mills
Non-parametric quantification of protein lysate arrays.
Bioinformatics (Oxford, England) 2007;23(15):1986-94.
2007: Taimur Sher; Bryan T. J. Hennessy; Vicente Valero; Kristine Broglio; Wendy A Woodward; Jonathan Trent; Kelly K Hunt; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Primary angiosarcomas of the breast.
Cancer 2007;110(1):173-8.
2007: Wei Tse Yang; Bryan T. J. Hennessy; Mark J Dryden; Vicente Valero; Kelly K Hunt; Savitri Krishnamurthy
Mammary angiosarcomas: imaging findings in 24 patients.
Radiology 2007;242(3):725-34.
2007: Jiyong Liang; Shan H Shao; Zhi-Xiang Xu; Bryan T. J. Hennessy; Zhiyong Ding; Michelle Larrea; Seiji Kondo; Dan J Dumont; Jordan U Gutterman; Cheryl Lyn Walker; Joyce M Slingerland; Gordon B Mills
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
Nature cell biology 2007;9(2):218-24.
2006: Michael Davies; Bryan T. J. Hennessy; Gordon B Mills
Point mutations of protein kinases and individualised cancer therapy.
Expert opinion on pharmacotherapy 2006;7(16):2243-61.
2006: Katherine Stemke-Hale; Bryan T. J. Hennessy; Gordon B Mills; Rahul Mitra
Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.
Current oncology reports 2006;8(6):484-91.
2006: I Blancas; J L García-Puche; Begoñia Bermejo; Emer O Hanrahan; C Monteagudo; A Martínez-Agulló; Roman Rouzier; Bryan T. J. Hennessy; Vicente Valero; Ana Lluch
Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1644-9.
2006: Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan T. J. Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
Molecular cancer therapeutics 2006;5(10):2512-21.
2006: Bryan T. J. Hennessy; Sharon H Giordano; Kristine Broglio; Zhigang Duan; Jonathan Trent; Thomas Buchholz; G Babiera; Gabriel N Hortobagyi; Vicente Valero
Biphasic metaplastic sarcomatoid carcinoma of the breast.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):605-13.
2006: Bryan T. J. Hennessy; Meera Nanjundan; Kwai Wa Cheng; Laura Nolden; Gordon B Mills
Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.
European journal of human genetics : EJHG 2006;14(4):381-3.
2006: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Massimo Cristofanilli; Shu-Wan Kau; Kristine Broglio; Bruno D Fornage; S Eva Singletary; Aysegul Sahin; Aman U Buzdar; Vicente Valero
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
Cancer 2006;106(5):1000-6.
2006: Bryan T. J. Hennessy; Gordon B Mills
Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.
The international journal of biochemistry & cell biology 2006;38(9):1450-6.
2005: Bryan T. J. Hennessy; Gabriel N Hortobagyi; Roman Rouzier; Henry M Kuerer; Nour Sneige; Aman U Buzdar; Shu-Wan Kau; Bruno D Fornage; Aysegul Sahin; Kristine Broglio; S Eva Singletary; Vicente Valero
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9304-11.
2005: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.
Nature clinical practice. Oncology 2005;2(12):598-9.
2005: Bryan T. J. Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Exploiting the PI3K/AKT pathway for cancer drug discovery.
Nature reviews. Drug discovery 2005;4(12):988-1004.
2005: Bryan T. J. Hennessy; Savitri Krishnamurthy; Sharon H Giordano; Thomas Buchholz; Shu-Wan Kau; Zhigang Duan; Vicente Valero; Gabriel N Hortobagyi
Squamous cell carcinoma of the breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7827-35.
2005: William G Davis; Bryan T. J. Hennessy; Gildy V Babiera; Kelly Hunt; Vicente Valero; Thomas Buchholz; Nour Sneige; Michael Z Gilcrease
Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer.
The American journal of surgical pathology 2005;29(11):1456-63.
2005: Emer O Hanrahan; Bryan T. J. Hennessy; Vicente Valero
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
Expert opinion on pharmacotherapy 2005;6(9):1477-91.
2005: Bryan T. J. Hennessy; A M Gauthier; L B Michaud; Gabriel N Hortobagyi; Vicente Valero
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1289-96.
2005: Bryan T. J. Hennessy; L Pusztai
Adjuvant therapy for breast cancer.
Minerva ginecologica 2005;57(3):305-26.
2005: Patrick J Hayden; A O'Driscoll; N Gardiner; Ronan T Swords; J Sargent; F Ni Ainle; A Fortune; Philip T Murphy; M Leahy; F Jackson; M Ryan; Bryan T. J. Hennessy; M Cahill; Gerard Crotty; Helen Enright; Eibhlin Conneally; Elisabeth Vandenberghe; Shaun R McCann; Paul V Browne
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003.
Irish journal of medical science 2005;174(2):26-32.
2005: Bryan T. J. Hennessy; Deborah A Thomas; Francis Giles; Andrew Lamb; Srdan Verstovsek
New approaches in the treatment of myelofibrosis.
Cancer 2005;103(1):32-43.
2004: Bryan T. J. Hennessy; Francis Giles; Jorge Cortes; Susan O'Brien; Alessandra Ferrajoli; Gladys Ossa; Guillermo Garcia-Manero; Stefan Faderl; Andrew Lamb; Srdan Verstovsek
Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
American journal of hematology 2004;77(3):209-14.
2004: Bryan T. J. Hennessy; Emer O Hanrahan; Peter A Daly
Non-Hodgkin lymphoma: an update.
The lancet oncology 2004;5(6):341-53.
2004: Bryan T. J. Hennessy; Martin Körbling; Z Estrov
Circulating stem cells and tissue repair.
Panminerva medica 2004;46(1):1-11.
2003: Bryan T. J. Hennessy; Guillermo Garcia-Manero; Hagop M Kantarjian; Francis Giles
DNA methylation in haematological malignancies: the role of decitabine.
Expert opinion on investigational drugs 2003;12(12):1985-93.
2003: Bryan T. J. Hennessy; Anne M Horgan; M Hogan; J Barry; S O Reilly; Oscar S Breathnach
Challenging problems in advanced malignancy: Case 4. Use of positron emission tomography to solve a diagnostic dilemma in a patient with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3173-6.
2003: Bryan T. J. Hennessy; Emer O Hanrahan; Oscar S Breathnach
Chemotherapy options for the elderly patient with advanced non-small cell lung cancer.
The oncologist 2003;8(3):270-7.
2002: Bryan T. J. Hennessy; J A McCaffrey; P Daly; Paul V Browne; MJ Kennedy
High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy.
Irish journal of medical science 2002;171(3):158-60.
2001: Bryan T. J. Hennessy; MJ Kennedy
High dose therapy for breast cancer: the European experience.
Breast disease 2001;14():3-7.